Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010 (2010), Article ID 513948, 20 pages
http://dx.doi.org/10.1155/2010/513948
Review Article

Release of Inflammatory Mediators by Human Adipose Tissue Is Enhanced in Obesity and Primarily by the Nonfat Cells: A Review

Department of Molecular Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USA

Received 3 November 2009; Revised 27 January 2010; Accepted 23 February 2010

Academic Editor: Giamila Fantuzzi

Copyright © 2010 John N. Fain. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Trayhurn and I. S. Wood, “Adipokines: inflammation and the pleiotropic role of white adipose tissue,” British Journal of Nutrition, vol. 92, no. 3, pp. 347–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Engeli and A. M. Sharma, “Role of adipose tissue for cardiovascular-renal regulation in health and disease,” Hormone and Metabolic Research, vol. 32, no. 11-12, pp. 485–499, 2000. View at Google Scholar · View at Scopus
  3. A. W. Ferrante Jr., “Obesity-induced inflammation: a metabolic dialogue in the language of inflammation,” Journal of Internal Medicine, vol. 262, no. 4, pp. 408–414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. K. M. Pou, J. M. Massaro, U. Hoffmann et al., “Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study,” Circulation, vol. 116, no. 11, pp. 1234–1241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Clement and D. Langin, “Regulation of inflammation-related genes in human adipose tissue,” Journal of Internal Medicine, vol. 262, no. 4, pp. 422–430, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. K. E. Wellen and G. S. Hotamisligil, “Inflammation, stress, and diabetes,” Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111–1119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M.-E. Piche, A. Lapointe, S. J. Weisnagel et al., “Regional body fat distribution and metabolic profile in postmenopausal women,” Metabolism, vol. 57, no. 8, pp. 1101–1107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Canoy, S. M. Boekholdt, N. Wareham et al., “Body fat distribution and risk of coronary heart disease in men and women in the european prospective investigation into cancer and nutrition in norfolk cohort: a population-based prospective study,” Circulation, vol. 116, no. 25, pp. 2933–2943, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J.-P. Despres, I. Lemieux, J. Bergeron et al., “Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 6, pp. 1039–1049, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. C. T. Montague and S. O'Rahilly, “The perils of portliness: causes and consequences of visceral adiposity,” Diabetes, vol. 49, no. 6, pp. 883–888, 2000. View at Google Scholar · View at Scopus
  11. C. E. Hallgreen and K. D. Hall, “Allometric relationship between changes of visceral fat and total fat mass,” International Journal of Obesity, vol. 32, no. 5, pp. 845–852, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Shen, M. Punyanitya, J. Chen et al., “Waist circumference correlates with metabolic syndrome indicators better than percentage fat,” Obesity, vol. 14, no. 4, pp. 727–736, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Scherzer, W. Shen, P. Bacchetti et al., “Simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects,” American Journal of Clinical Nutrition, vol. 87, no. 6, pp. 1809–1817, 2008. View at Google Scholar · View at Scopus
  14. B. Siegmund, J. A. Sennello, J. Jones-Carson et al., “Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice,” Gut, vol. 53, no. 7, pp. 965–972, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Sanna, A. Di Giacomo, A. La Cava et al., “Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses,” Journal of Clinical Investigation, vol. 111, no. 2, pp. 241–250, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Xu, Y. Wang, J. Y. Xu et al., “Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome,” Clinical Chemistry, vol. 52, no. 3, pp. 405–413, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Stejskal, M. Karpisek, H. Reutova, P. Stejskal, H. Kotolova, and P. Kollar, “Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA,” Clinical Biochemistry, vol. 41, no. 4-5, pp. 313–316, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Simon, X. Escote, N. Vilarrasa et al., “Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women,” Obesity, vol. 17, no. 6, pp. 1124–1128, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. F. M. H. van Dielen, C. Van't Veer, A. M. Schols, P. B. Soeters, W. A. Buurman, and J. W. M. Greve, “Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals,” International Journal of Obesity, vol. 25, no. 12, pp. 1759–1766, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. A. E. Malavazos, E. Cereda, L. Morricone, C. Coman, M. M. Corsi, and B. Ambrosi, “Monocyte chemoattractant protein 1: a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity,” European Journal of Endocrinology, vol. 153, no. 6, pp. 871–877, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Straczkowski, S. Dzienis-Straczkowska, A. Stepien, I. Kowalska, M. Szelachowska, and I. Kinalska, “Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-α system,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 10, pp. 4602–4606, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. C.-S. Kim, H.-S. Park, T. Kawada et al., “Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters,” International Journal of Obesity, vol. 30, no. 9, pp. 1347–1355, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M.-C. Alessi, M. Poggi, and I. Juhan-Vague, “Plasminogen activator inhibitor-1, adipose tissue and insulin resistance,” Current Opinion in Lipidology, vol. 18, no. 3, pp. 240–245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Skurk and H. Hauner, “Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1,” International Journal of Obesity, vol. 28, no. 11, pp. 1357–1364, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Madani, K. Karastergiou, N. C. Ogston et al., “RANTES release by human adipose tissue in vivo and evidence for depot-specific differences,” American Journal of Physiology, vol. 296, no. 6, pp. E1262–E1268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Vozarova, C. Weyer, K. Hanson, P. A. Tataranni, C. Bogardus, and R. E. Pratley, “Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion,” Obesity Research, vol. 9, no. 7, pp. 414–417, 2001. View at Google Scholar · View at Scopus
  27. A. Cartier, I. Lemieux, N. Almeras, A. Tremblay, J. Bergeron, and J.-P. Despres, “Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-α in men,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 5, pp. 1931–1938, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Esposito, A. Pontillo, F. Giugliano et al., “Association of low interleukin-10 levels with the metabolic syndrome in obese women,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 3, pp. 1055–1058, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Ziccardi, F. Nappo, G. Giugliano et al., “Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year,” Circulation, vol. 105, no. 7, pp. 804–809, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Khaodhiar, P.-R. Ling, G. L. Blackburn, and B. R. Bistrian, “Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity,” Journal of Parenteral and Enteral Nutrition, vol. 28, no. 6, pp. 410–415, 2004. View at Google Scholar · View at Scopus
  31. J. S. Yudkin, C. D. A. Stehouwer, J. J. Emeis, and S. W. Coppack, “C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 4, pp. 972–978, 1999. View at Google Scholar · View at Scopus
  32. A. Napolitano, B. B. Lowell, D. Damm et al., “Concentrations of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass,” International Journal of Obesity, vol. 18, no. 4, pp. 213–218, 1994. View at Google Scholar · View at Scopus
  33. P. A. Kern, G. B. Di Gregorio, T. Lu, N. Rassouli, and G. Ranganathan, “Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression,” Diabetes, vol. 52, no. 7, pp. 1779–1785, 2003. View at Google Scholar · View at Scopus
  34. N. Suwaki, H. Masuyama, H. Nakatsukasa et al., “Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia,” American Journal of Obstetrics and Gynecology, vol. 195, no. 6, pp. 1687–1692, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. S. Lee, A. Y. Kim, J. W. Choi et al., “Dysregulation of adipose glutathione peroxidase 3 in obesity contributes to local and systemic oxidative stress,” Molecular Endocrinology, vol. 22, no. 9, pp. 2176–2189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. C. A. Meier, E. Bobbioni, C. Gabay, F. Assimacopoulos-Jeannet, A. Golay, and J.-M. Dayer, “IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 3, pp. 1184–1188, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. R.-Z. Yang, M.-J. Lee, H. Hu et al., “Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications,” PLoS Medicine, vol. 3, no. 6, pp. 884–894, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Dandona, A. Aljada, H. Ghanim et al., “Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 10, pp. 5043–5047, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Retnakaran, B.-S. Youn, Y. Liu et al., “Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study,” Clinical Endocrinology, vol. 69, no. 6, pp. 885–893, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Korner, A. Garten, M. Bluher, R. Tauscher, J. Kratzsch, and W. Kiess, “Molecular characteristics of serum visfatin and differential detection by immunoassays,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 12, pp. 4783–4791, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. J. K. Sethi, “Is PBEF/Visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome?” Current Hypertension Reports, vol. 9, no. 1, pp. 33–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. J. N. Fain, B. M. Tagele, P. Cheema, A. K. Madan, and D. S. Tichansky, “Release of 12 adipokines by human adipose tissue, non-fat cells and adipocytes,” Obesity, vol. 18, no. 5, pp. 890–896, 2010. View at Google Scholar
  43. D. Stejskal, M. Karpisek, V. Humenanska et al., “Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA,” Hormone and Metabolic Research, vol. 40, no. 6, pp. 381–385, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Taleb and K. Clement, “Emerging role of cathepsin S in obesity and its associated diseases,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 3, pp. 328–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. M.-H. Gannage-Yared, C. Yaghi, B. Habre et al., “Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study,” European Journal of Endocrinology, vol. 158, no. 3, pp. 353–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Rehman, R. V. Considine, J. E. Bovenkerk et al., “Obesity is associated with increased levels of circulating hepatocyte growth factor,” Journal of the American College of Cardiology, vol. 41, no. 8, pp. 1408–1413, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Kobayashi, K. Nakajima, A. Nohara et al., “The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients,” Hormone and Metabolic Research, vol. 39, no. 8, pp. 612–616, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. P. C. Scriba, M. Bauer, and D. Emmert, “Effects of obesity, total fasting and re-alimentation on L-thyroxine (T4), 3,5,3-L-triiodothyronine (T3), 3,3,5-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding globulin (CBG), transferrin, alpha 2-haptoglobin and complement C'3 in serum,” Acta Endocrinologica, vol. 91, no. 4, pp. 629–643, 1979. View at Google Scholar
  49. C. Couillard, G. Ruel, W. R. Archer et al., “Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 12, pp. 6454–6459, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. J. B. Harp, S. A. Henry, and M. DiGirolamo, “Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults,” Obesity Research, vol. 10, no. 10, pp. 985–990, 2002. View at Google Scholar · View at Scopus
  51. S. Miyazawa-Hoshimoto, K. Takahashi, H. Bujo, N. Hashimoto, and Y. Saito, “Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects,” Diabetologia, vol. 46, no. 11, pp. 1483–1488, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Dandona, R. Weinstock, K. Thusu, E. Abdel-Rahman, A. Aljada, and T. Wadden, “Tumor necrosis factor-α in sera of obese patients: fall with weight loss,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 8, pp. 2907–2910, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Scaglione, C. Argano, T. di Chiara et al., “Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor ß1 and urinary albumin excretion,” Blood Pressure, vol. 12, no. 5-6, pp. 269–276, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. J.-M. Fernandez-Real, M. Broch, W. Ricart et al., “Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance,” Diabetes, vol. 47, no. 11, pp. 1757–1762, 1998. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Bullo, M. R. Peeraully, P. Trayhurn, J. Folch, and J. Salas-Salvado, “Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women,” European Journal of Endocrinology, vol. 157, no. 3, pp. 303–310, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. N. Iqbal, P. Seshadri, L. Stern et al., “Serum resistin is not associated with obesity or insulin resistance in humans,” European Review for Medical and Pharmacological Sciences, vol. 9, no. 3, pp. 161–165, 2005. View at Google Scholar · View at Scopus
  57. J. H. Lee, J. L. Chan, N. Yiannakouris et al., “Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 10, pp. 4848–4856, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Festa, R. D'Agostino Jr., K. Williams et al., “The relation of body fat mass and distribution to markers of chronic inflammation,” International Journal of Obesity, vol. 25, no. 10, pp. 1407–1415, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Esposito, A. Pontillo, M. Ciotola et al., “Weight loss reduces interleukin-18 levels in obese women,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 8, pp. 3864–3866, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. G.-H. Schernthaner, H.-P. Kopp, S. Kriwanek et al., “Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity,” Obesity Surgery, vol. 16, no. 6, pp. 709–715, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. J. N. Fain, P. Cheema, D. S. Tichansky, and A. K. Madan, “The inflammatory response seen when human omental adipose tissue explants are incubated in primary culture is not dependent upon albumin and is primarily in the nonfat cells,” Journal of Inflammation, vol. 7, article 4, 2010. View at Google Scholar
  62. J. N. Fain, A. K. Madan, M. L. Hiler, P. Cheema, and S. W. Bahouth, “Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans,” Endocrinology, vol. 145, no. 5, pp. 2273–2282, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. J. N. Fain, S. W. Bahouth, and A. K. Madan, “Haptoglobin release by human adipose tissue in primary culture,” Journal of Lipid Research, vol. 45, no. 3, pp. 536–542, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. J. N. Fain, P. S. Cheema, S. W. Bahouth, and M. L. Hiler, “Resistin release by human adipose tissue explants in primary culture,” Biochemical and Biophysical Research Communications, vol. 300, no. 3, pp. 674–678, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. J. N. Fain and A. K. Madan, “Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue,” International Journal of Obesity, vol. 29, no. 11, pp. 1299–1307, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. J. N. Fain, D. S. Tichansky, and A. K. Madan, “Transforming growth factor β1 release by human adipose tissue is enhanced in obesity,” Metabolism, vol. 54, no. 11, pp. 1546–1551, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. J. N. Fain, D. S. Tichansky, and A. K. Madan, “Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non-fat cells, not by the adipocytes,” Metabolism, vol. 55, no. 8, pp. 1113–1121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. J. N. Fain, A. S. Nesbit, F. F. Sudlow et al., “Release in vitro of adipsin, vascular cell adhesion molecule 1, angiotensin 1-converting enzyme, and soluble tumor necrosis factor receptor 2 by human omental adipose tissue as well as by the nonfat cells and adipocytes,” Metabolism, vol. 56, no. 11, pp. 1583–1590, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Mracek, Q. Ding, T. Tzanavari et al., “The adipokine zinc-a2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity,” Clinical Endocrinology, vol. 72, no. 3, pp. 334–341, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. M. P. Marrades, J. A. Martinez, and M. J. Moreno-Aliaga, “ZAG, a lipid mobilizing adipokine, is downregulated in human obesity,” Journal of Physiology and Biochemistry, vol. 64, no. 1, pp. 61–66, 2008. View at Google Scholar · View at Scopus
  71. S. Mocellin, M. C. Panelli, E. Wang, D. Nagorsen, and F. M. Marincola, “The dual role of IL-10,” Trends in Immunology, vol. 24, no. 1, pp. 36–43, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Kim, R. A. Bachmann, and J. Chen, “Chapter 21 interleukin-6 and insulin resistance,” Vitamins and Hormones, vol. 80, pp. 613–633, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. Z. Orban, A. T. Remaley, M. Sampson, Z. Trajanoski, and G. P. Chrousos, “The differential effect of food intake and β-adrenergic stimulation on adipose-derived hormones and cytokines in man,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 6, pp. 2126–2133, 1999. View at Google Scholar · View at Scopus
  74. J.-P. Bastard, M. Maachi, J. T. Van Nhieu et al., “Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 5, pp. 2084–2089, 2002. View at Publisher · View at Google Scholar · View at Scopus
  75. C. Bierl, B. Voetsch, R. C. Jin, D. E. Handy, and J. Loscalzo, “Determinants of human plasma glutathione peroxidase (GPx-3) expression,” Journal of Biological Chemistry, vol. 279, no. 26, pp. 26839–26845, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Dogru-Abbasoglu, O. Kanbagli, H. Bulur et al., “Lipid peroxides and antioxidant status in serum of patients with angiographically defined coronary atherosclerosis,” Clinical Biochemistry, vol. 32, no. 8, pp. 671–672, 1999. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Rodbell, “Localization of lipoprotein lipase in fat cells of rat adipose tissue,” The Journal of Biological Chemistry, vol. 239, no. 3, pp. 753–755, 1964. View at Google Scholar
  78. M. Rodbell, “Metabolism of isolated fat cell. 1. Effects of hormones on glucose metabolism and lipolysis,” The Journal of Biological Chemistry, vol. 239, no. 2, pp. 375–380, 1964. View at Google Scholar
  79. W. H. Cleland, C. R. Mendelson, and E. R. Simpson, “Aromatase activity of membrane fractions of human adipose tissue stromal cells and adipocytes,” Endocrinology, vol. 113, no. 6, pp. 2155–2160, 1983. View at Google Scholar · View at Scopus
  80. S. K. Fried, D. A. Bunkin, and A. S. Greenberg, “Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 3, pp. 847–850, 1998. View at Publisher · View at Google Scholar · View at Scopus
  81. J. N. Fain, S. W. Bahouth, and A. K. Madan, “Involvement of multiple signaling pathways in the post-bariatric induction of IL-6 and IL-8 mRNA and release in human visceral adipose tissue,” Biochemical Pharmacology, vol. 69, no. 9, pp. 1315–1324, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. J. N. Fain, B. Buehrer, D. S. Tichansky, and A. K. Madan, “Regulation of adiponectin release and demonstration of adiponectin mRNA as well as release by the non-fat cells of human omental adipose tissue,” International Journal of Obesity, vol. 32, no. 3, pp. 429–435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. J. N. Fain, B. Buehrer, S. W. Bahouth, D. S. Tichansky, and A. K. Madan, “Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue,” Metabolism, vol. 57, no. 7, pp. 1005–1015, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. Bao, C. Bing, L. Hunter, J. R. Jenkins, M. Wabitsch, and P. Trayhurn, “Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes,” FEBS Letters, vol. 579, no. 1, pp. 41–47, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. M. M. Hill, S. F. Clark, D. F. Tucker, M. J. Birnbaum, D. E. James, and S. L. Macaulay, “A role for protein kinase Bβ/Akt2 in insulin-stimulated GLUT4 translocation in adipocytes,” Molecular and Cellular Biology, vol. 19, no. 11, pp. 7771–7781, 1999. View at Google Scholar · View at Scopus
  86. H. S. Sacks, J. N. Fain, B. Holman et al., “Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 9, pp. 3611–3615, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. C. Deveaud, B. Beauvoit, B. Salin, J. Schaeffer, and M. Rigoulet, “Regional differences in oxidative capacity of rat white adipose tissue are linked to the mitochondrial content of mature adipocytes,” Molecular and Cellular Biochemistry, vol. 267, no. 1-2, pp. 157–166, 2004. View at Publisher · View at Google Scholar · View at Scopus
  88. O. Paulmyer-Lacroix, R. Desbriere, M. Poggi et al., “Expression of adrenomedullin in adipose tissue of lean and obese women,” European Journal of Endocrinology, vol. 155, no. 1, pp. 177–185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. Y. Li, C. Jiang, X. Wang, Y. Zhang, S. Shibahara, and K. Takahashi, “Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues,” Peptides, vol. 28, no. 5, pp. 1129–1143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. R. Harmancey, J.-M. Senard, A. Pathak et al., “The vasoactive peptide adrenomedullin is secreted by adipocytes and inhibits lipolysis through NO-mediated ß-adrenergic agonist oxidation,” FASEB Journal, vol. 19, no. 8, pp. 1045–1047, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. C. Iemura-Inaba, T. Nishikimi, K. Akimoto, F. Yoshihara, N. Minamino, and H. Matsuoka, “Role of adrenomedullin system in lipid metabolism and its signaling mechanism in cultured adipocytes,” American Journal of Physiology, vol. 295, no. 5, pp. R1376–R1384, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. N. Kloting, J. Berndt, S. Kralisch et al., “Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes,” Biochemical and Biophysical Research Communications, vol. 339, no. 1, pp. 430–436, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. C. M. de Souza Batista, R.-Z. Yang, M.-J. Lee et al., “Omentin plasma levels and gene expression are decreased in obesity,” Diabetes, vol. 56, no. 6, pp. 1655–1661, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. S. A. Bustin, “Absolute quantification of mrna using real-time reverse transcription polymerase chain reaction assays,” Journal of Molecular Endocrinology, vol. 25, no. 2, pp. 169–193, 2000. View at Google Scholar · View at Scopus
  95. J. E. Davis, N. K. Gabler, J. Walker-Daniels, and M. E. Spurlock, “Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat,” Obesity, vol. 16, no. 6, pp. 1248–1255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. J. N. Fain, S. W. Bahouth, and A. K. Madan, “TNFα release by the nonfat cells of human adipose tissue,” International Journal of Obesity, vol. 28, no. 4, pp. 616–622, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. B. Hellman, S. Larsson, and S. Westman, “Mast cell content and fatty acid metabolism in the epididymal fat pad of obese mice,” Acta Physiologica Scandinavica, vol. 58, pp. 255–262, 1963. View at Google Scholar · View at Scopus
  98. H. Xu, G. T. Barnes, Q. Yang et al., “Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821–1830, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., “Obesity is associated with macrophage accumulation in adipose tissue,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  100. R. Cancello, J. Tordjman, C. Poitou et al., “Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity,” Diabetes, vol. 55, no. 6, pp. 1554–1561, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. L. A. Kunz-Schughart, A. Weber, M. Rehli et al., “The “classical” macrophage marker CD68 is strongly expressed in primary human fibroblasts,” Verhandlungen der Deutschen Gesellschaft für Pathologie, vol. 87, pp. 215–223, 2003. View at Google Scholar
  102. W. Khazen, J.-P. M'Bika, C. Tomkiewicz et al., “Expression of macrophage-selective markers in human and rodent adipocytes,” FEBS Letters, vol. 579, no. 25, pp. 5631–5634, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Cinti, G. Mitchell, G. Barbatelli et al., “Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans,” Journal of Lipid Research, vol. 46, no. 11, pp. 2347–2355, 2005. View at Publisher · View at Google Scholar · View at Scopus
  104. I. Murano, G. Barbatelli, V. Parisani et al., “Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice,” Journal of Lipid Research, vol. 49, no. 7, pp. 1562–1568, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. P. Arner, “The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones,” Trends in Endocrinology and Metabolism, vol. 14, no. 3, pp. 137–145, 2003. View at Publisher · View at Google Scholar · View at Scopus
  106. J. N. Fain, H. S. Sacks, S. W. Bahouth, D. S. Tichansky, A. K. Madan, and P. S. Cheema, “Human epicardial adipokine messenger RNAs: comparisons of their expression in substernal, subcutaneous, and omental fat,” Metabolism. In press.
  107. H. Esterbauer, H. Oberkofler, Y.-M. Liu et al., “Uncoupling protein-1 mRNA expression in obese human subjects: the role of sequence variations at the uncoupling protein-1 gene locus,” Journal of Lipid Research, vol. 39, no. 4, pp. 834–844, 1998. View at Google Scholar · View at Scopus
  108. J. N. Fain, H. S. Sacks, B. Buehrer et al., “Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots,” International Journal of Obesity, vol. 32, no. 5, pp. 810–815, 2008. View at Publisher · View at Google Scholar · View at Scopus
  109. F. Giorgino, L. Laviola, and J. W. Eriksson, “Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies,” Acta Physiologica Scandinavica, vol. 183, no. 1, pp. 13–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. B. L. Wajchenberg, “Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome,” Endocrine Reviews, vol. 21, no. 6, pp. 697–738, 2000. View at Publisher · View at Google Scholar · View at Scopus
  111. G. He, S. B. Pedersen, J. M. Bruun, A. S. Lihn, P. F. Jensen, and B. Richelsen, “Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects,” Hormone and Metabolic Research, vol. 35, no. 3, pp. 178–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  112. P. Eriksson, V. Van Harmelen, J. Hoffstedt et al., “Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals,” Thrombosis and Haemostasis, vol. 83, no. 4, pp. 545–548, 2000. View at Google Scholar · View at Scopus
  113. V. Harmelen, S. Reynisdottir, P. Eriksson et al., “Leptin secretion from subcutaneous and visceral adipose tissue in women,” Diabetes, vol. 47, no. 6, pp. 913–917, 1998. View at Publisher · View at Google Scholar · View at Scopus
  114. C. D. Russell, R. N. Petersen, S. P. Rao et al., “Leptin expression in adipose tissue from obese humans: depot-specific regulation by insulin and dexamethasone,” American Journal of Physiology, vol. 275, no. 3, pp. E507–E515, 1998. View at Google Scholar · View at Scopus
  115. E. Dusserre, P. Moulin, and H. Vidal, “Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues,” Biochimica et Biophysica Acta, vol. 1500, no. 1, pp. 88–96, 2000. View at Publisher · View at Google Scholar · View at Scopus
  116. S. Reynisdottir, M. Dauzats, A. Thorne, and D. Langin, “Comparison of hormone-sensitive lipase activity in visceral and subcutaneous human adipose tissue,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 12, pp. 4162–4166, 1997. View at Google Scholar · View at Scopus
  117. A.-M. Lefebvre, M. Laville, N. Vega et al., “Depot-specific differences in adipose tissue gene expression in lean and obese subjects,” Diabetes, vol. 47, no. 1, pp. 98–103, 1998. View at Google Scholar · View at Scopus
  118. E. Arvidsson, L. Blomqvist, and M. Ryden, “Depot-specific differences in perilipin mRNA but not protein expression in obesity,” Journal of Internal Medicine, vol. 255, no. 5, pp. 595–601, 2004. View at Publisher · View at Google Scholar · View at Scopus
  119. H. S. Sacks and J. N. Fain, “Human epicardial adipose tissue: a review,” American Heart Journal, vol. 153, pp. 907–917, 2007. View at Publisher · View at Google Scholar · View at Scopus
  120. N. Kloting, S. Berthold, P. Kovacs et al., “MicroRNA expression in human omental and subcutaneous adipose tissue,” PLoS One, vol. 4, no. 3, article e4699, 2009. View at Publisher · View at Google Scholar · View at Scopus
  121. D. M. L. Tsukumo, M. A. Carvalho-Filho, J. B. C. Carvalheira et al., “Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance,” Diabetes, vol. 56, no. 8, pp. 1986–1998, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. A. Schaeffler, P. Gross, R. Buettner et al., “Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-?B pathway in adipocytes links nutritional signalling with innate immunity,” Immunology, vol. 126, no. 2, pp. 233–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  123. J. Y. Lee, K. H. Sohn, S. H. Rhee, and D. Hwang, “Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4,” Journal of Biological Chemistry, vol. 276, no. 20, pp. 16683–16689, 2001. View at Publisher · View at Google Scholar · View at Scopus
  124. Y. Lin, H. Lee, A. H. Berg, M. P. Lisanti, L. Shapiro, and P. E. Scherer, “The lipopolysaccharide-activated Toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes,” Journal of Biological Chemistry, vol. 275, no. 32, pp. 24255–24263, 2000. View at Publisher · View at Google Scholar · View at Scopus
  125. O. I. Vitseva, K. Tanriverdi, T. T. Tchkonia et al., “Inducible toll-like receptor and NF-?B regulatory pathway expression in human adipose tissue,” Obesity, vol. 16, no. 5, pp. 932–937, 2008. View at Publisher · View at Google Scholar · View at Scopus
  126. S. Bès-Houtmann, R. Roche, L. Hoareau et al., “Presence of functional TLR2 and TLR4 on human adipocytes,” Histochemistry and Cell Biology, vol. 127, no. 2, pp. 131–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  127. J. M. Zha, W. J. Di, T. Zhu et al., “Comparison of gene transcription between subcutaneous and visceral adipose tissue in Chinese adults,” Endocrine Journal, vol. 56, no. 8, pp. 935–944, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. J. N. Fain, P. Cheema, A. K. Madan, and D. S. Tichansky, “Dexamethasone and the inflammatory response in explants of human omental adipose tissue,” Molecular and Cellular Endocrinology, vol. 315, no. 1-2, pp. 292–298, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. T. Suganami, K. Tanimoto-Koyama, J. Nishida et al., “Role of the Toll-like receptor 4/NF-?B pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 84–91, 2007. View at Publisher · View at Google Scholar · View at Scopus
  130. L. Zu, J. He, H. Jiang, C. Xu, S. Pu, and G. Xu, “Bacterial endotoxin stimulates adipose lipolysis via toll-like receptor 4 and extracellular signal-regulated kinase pathway,” Journal of Biological Chemistry, vol. 284, no. 9, pp. 5915–5926, 2009. View at Publisher · View at Google Scholar · View at Scopus
  131. P. Trayhurn, B. Wang, and I. S. Wood, “Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?” British Journal of Nutrition, vol. 100, no. 2, pp. 227–235, 2008. View at Publisher · View at Google Scholar · View at Scopus
  132. J. Ye, “Emerging role of adipose tissue hypoxia in obesity and insulin resistance,” International Journal of Obesity, vol. 33, no. 1, pp. 54–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  133. J. Yin, Z. Gao, Q. He, D. Zhou, Z. Guo, and J. Ye, “Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue,” American Journal of Physiology, vol. 296, no. 2, pp. E333–E342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  134. J. Ye, Z. Gao, J. Yin, and Q. He, “Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice,” American Journal of Physiology, vol. 293, no. 4, pp. E1118–E1128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  135. M. E. Rausch, S. Weisberg, P. Vardhana, and D. V. Tortoriello, “Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration,” International Journal of Obesity, vol. 32, no. 3, pp. 451–463, 2008. View at Publisher · View at Google Scholar · View at Scopus
  136. J. N. Fain, P. Cheema, D. S. Tichansky, and A. K. Madan, “Stimulation of human omental adipose tissue lipolysis by growth hormone plus dexamethasone,” Molecular and Cellular Endocrinology, vol. 295, no. 1-2, pp. 101–105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  137. N. Halberg, T. Khan, M. E. Trujillo et al., “Hypoxia-inducible factor 1a induces fibrosis and insulin resistance in white adipose tissue,” Molecular and Cellular Biology, vol. 29, no. 16, pp. 4467–4483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  138. J. M. Bruun, A. S. Lihn, A. K. Madan et al., “Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue,” American Journal of Physiology, vol. 286, no. 1, pp. E8–E13, 2004. View at Google Scholar · View at Scopus